Patent details

Basic Information

Publication number:

EP2205639

PCT Application Number:

PCT/US/2008/081311

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088412317

PCT Publication Number:

WO/2009/055783

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-PCSK9 AND METHODS FOR TREATING LIPID AND CHOLESTEROL DISORDERS

French Title of Invention:

ANTI-PCSK9 ET MÉTHODES DE TRAITEMENT DE TROUBLES DU MÉTABOLISME LIPIDIQUE ET DU CHOLESTÉROL

German Title of Invention:

ANTI-PCSK9 UND VERFAHREN ZUR BEHANDLUNG VON STÖRUNGEN DES LIPID- UND CHOLESTERINHAUSHALTES

SPC Number:

Dates

Filing date:

27/10/2008

Grant date:

23/12/2015

EP Publication Date:

23/12/2015

PCT Publication Date:

30/04/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/07/2010

EP B1 Publication Date:

23/12/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/10/2016

Expiration date:

27/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/10/2008

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

HEDRICK Joseph A.

Address:

United States (US)

2

Name:

MONSMA Frederick James, Jr.

Address:

United States (US)

3

Name:

CHURAKOVA Tatyana

Address:

United States (US)

4

Name:

HOLLENBAUGH Diane

Address:

United States (US)

Priority

Priority Number:

982922 P

Priority Date:

26/10/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/40;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages